Determination of the ABO blood groups and double determination of RhD, combined with reverse grouping.

ID-Card (Id-n°: 50981):

•Configuration: A, B, DVI+, DVI-, A1, B
•Cell lines: A: A5 / B: G1/2, D: ESD-1M,175-2 / D: LHM 50/3 (LDM1)/TH-28/ RUM-1

ABO/D + Reverse Grouping ID-Card contains monoclonal anti-A, anti-B and anti-D within the gel matrix.

ID-Card (Id-n°: 50092):
•Configuration: A, B, DVI-, ctl/A1, B
•Cell lines: A: A5 / B: G1/2, D: LHM59/20 (LDM3), 175-2

The ID-Card DiaClon ABO/D + Reverse Grouping for Donors allows combined testing of forward and reverse grouping as well as RhD determination for confirmation of previously fully tested samples with established blood group status.

The monoclonal anti-D used has been selected so as to react with DVI variant.

ID-Card (Id-n°: 51090):
• Configuration: A, B, DVI+, ctl/A1, B
•Cell lines: A: A5, B: G1/2, D: ESD-1M, 175-2

Supplies on request (10 weeks delivery time)

DiaClon ABO/D contains two monocolonal D antibodies. The first anti-D detects the presence of the D variant DVI, and the second anti-D is negative for the DVI variant.

ID-Card (Id-n°: 50481):
•Configuration: A, B, AB, DVI+, DVI-, ctl
•Cell lines: A: A5 / B: G1/2, AB: ES131 (ES-15), Birma-1, ES-4
D: ESD-1M, 175-2, D: LHM59/20 (LDM3), 175-2

With the DiaClon ABO/D + DAT ID-Card, a complete profile for ABO forward typing and RhD status can be obtained in a single procedure, including a direct anti-human globulin test (DAT). The two anti-D antibodies in the ID-Card are negative for the variant DVI. The test procedure is thus suitable for patients and not recommended for donors.

ID-Card (Id-n°: 50492):
•Configuration: A, B, DVI-, DVI-, ctl, DAT
•Cell lines: A: A5 / B: G1/2, D: LHM50/3 (LDM1), TH-28, RUM-1,
D: LHM59/20 (LDM3), 175-2

DiaClon ABO/Rh for Patients offers a complete test profile for forward typing of ABO, plus RhD (DVI neg.) and CDE, in a single test procedure. Current recommendations for RhD typing suggest that, for transfusion recipients and antenatal patients, anti-D reagents should not detect the DVI phenotype. Individuals possessing the DVI phenotype may produce an anti-D to the missing epitopes after immunization by fetal or transfused RhD positive cells. To ensure that appropriate therapeutic measures are instigated, a DVI patient’s red cells should be assigned RhD negative status. Conversely, donor bloods should be tested with anti-D that does detect DVI and assigned RhD positive status, to avoid the unit being transfused to an RhD negative or partial-D patient.

ID-Card (Id-n°: 50012):
•Configuration: A, B, AB, DVI-, CDE, ctl
•Cell lines: A: A5 / B: G1/2, AB: ES131 (ES-15), Birma-1, ES-4,
D: LHM59/20 (LDM3) 175-2, CDE: MS-24, MS-26, MS-201, MS-80

The DiaClon ABO/Rh ID-Card for donors offers a complete test profile for forward typing of ABO plus RhD and CDE in a single test procedure. The monoclonal anti-D used has been selected so as to react with DVI variants. Donor bloods should be tested with anti-D that does detect DVI and assigned RhD positive status, to avoid the unit being transfused to an RhD negative or partial-D patient.

ID-Card
(Id-n°: 51011)
•Configuration: A, B, AB, DVI+, CDE, ctl
•Cell lines: A: A5 / B: G1/2, AB: ES131 (ES-15), Birma-1, ES-4,
D: ESD-1M, 175-2, CDE: MS-24, MS-26, MS-201, MS-80

The ID-Card DiaClon ABD-Confirmation for Patients can be used for the ABO/RhD blood group control of patients. Current recommendations for RhD typing suggest that, for transfusion recipients and antenatal patients, anti-D reagents should not detect the DVI phenotype. Individuals possessing the DVI phenotype may produce an anti-D to the missing epitopes after immunization by fetal or transfused RhD positive cells. To ensure that appropriate therapeutic measures are instigated, a DVI patient’s red cells should be assigned RhD negative status. Conversely, donor bloods should be tested with anti-D that does detect DVI and assigned RhD positive status, to avoid the unit being transfused to an RhD negative or partial-D patient.

ID-Card (Id-n°: 50053):
•Configuration: A, B, DVI-/A, B, DVI-
•Cell lines: A: LM297/628 (LA-2), B: LM306/686 (LB-2), D: TH28, RUM-1, LDM1

DiaClon ABD-Confirmation for Donors is used for the ABO/RhD blood group control of donors. Current recommendations for RhD typing suggest that, for transfusion recipients and antenatal patients, anti-D reagents should not detect the DVI phenotype. Individuals possessing the DVI phenotype may produce an anti-D to the missing epitopes after immunization by fetal or transfused RhD positive cells. To ensure that appropriate therapeutic measures are instigated, a DVI patient’s red cells should be assigned RhD negative status. Conversely, donor bloods should be tested with anti-D that does detect DVI and assigned RhD positive status, to avoid the unit being transfused to an RhD negative or partial-D patient.

ID-Card (Id-n°: 51051):
•Configuration: A, B, DVI+/A, B, DVI+
•Cell lines: A: LM297/628 (LA-2), B: LM306/686 (LB-2), D: ESD-1M, 175-2

ID-Card DiaClon ABO/Rh for newborns DVI+ uses monoclonal antisera and red cell suspension in ID-Diluent 2, without incubation. The anti-D used will not react with all examples of weak D (Dweak).

ID-Card
(Id-n°: 50961)
•Configuration: A, B, AB, DVI+, ctl, DAT
•Cell lines: A: LM297/628 (LA-2), B: LM306/686 (LB-2),
AB: ES131 (ES-15), Birma-1, ES-4, D: ESD-1M, 175-2

The monoclonal anti-D used in the DiaClon ABO/Rh for Newborns DVI- ID-Card has been selected so as not to react with DVI variants.

ID-Card
(Id-n°: 50071)
•Configuration: A, B, AB, DVI-, ctl, DAT
•Cell lines: A: LM297/628 (LA-2), B: LM306/686 (LB-2),
AB: ES131 (ES-15), Birma-1, ES-4, D: LDM3, 175-2

The ABO/D + Reverse Grouping ID-Card contains a mixture of human polyclonal and monoclonal anti-A, human polyclonal anti-B and human polyclonal anti-D antibodies. The microtube ctl is the negative control. Two microtubes with neutral gel serve for reverse grouping with A1 and B cells.

ID-Card (Id-n°: 50081):
•Human
•Configuration: A, B, D, ctl/A1, B

This ID-Card provides ABO/RhD typing in a single procedure, including the confirmation of RhD. The first anti-D is of human origin and may detect the presence of the D variant DVI. The second anti-D is monoclonal and is negative for the DVI variant. The sensitivity of the ID-System allows direct detection of Dweak, previously known as Du.

ID-Card (Id-n°: 50031):
•Configuration: A, B, AB, DVI+, DVI-, ctl
•Position 5 D: cell line 175-2

ABO/Rh provides a full antigen profile (ABO, RhD and CDE), in one test procedure.

ID-Card (Id-n°: 50001):
•Configuration: A, B, AB, D, CDE, ctl

The ABD Confirmation ID-Card is used for mandatory confirmations of current ABO/RhD groups against historical records.

ID-Card (Id-n°: 50041):
•Configuration: A, B, D/A, B, D

The ID-Card ABO/Rh for Newborns is used for the determination of ABO/Rh-antigens and the direct antiglobulin test (DAT) for newborns, using human antibodies. DAT has become a standard newborn sample procedure, since it is important to know if the newborn’s red cells have been sensitized with maternal antibodies in utero. Either cord or heel-prick samples can be used.

ID-Card (Id-n°: 50061):
•Configuration: A, B, AB, D, ctl/DAT